Companies/US/IVVD

INVIVYD, INC.

Last · NasdaqGM$0.6078-0.0382 (-5.91%)close · yahoo · 14h ago
Vol 3.89M ≈ 2.36M
Market cap$179.15M294.8M sh
P/E · TTM-2.4fwd -1.1 · eps -0.31 · loss
Beta0.95vs S&P 500
Div yield0.00%annual · TTM
52w range
$0.528$3.07
Volume3.9Msession

Issuer

Legal nameINVIVYD, INC.
HQUnited States (US)
ListingUS IVVD
ISINUS00534A1025
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0001832038
CIK0001832038
Employees122
AddressInvivyd, Inc. 209 Church Street 06510, New Haven
Headline financial metrics
Revenue$53.4M
Operating income$-55.6M
Net income$-52.5M
Free cash flow$-58.3M
Operating margin-104.0%
Net margin-98.2%
Return on equity-21.7%
Period2025
Loading chart…

OpenFilings analyst

Our analyst

10-K · 2026-03-05

From latest 10-K · 2026-03-05

  • Operating Cf Burn
  • Net Margin Sharply Negative
  • Cash Conversion Weak
  • Sbc Revenue Elevated
  • Accumulated Deficit High
  • Rd Intensity High

Red flags

  • Operating Cf Burn — Negative operating cash flow
  • Net Margin Sharply Negative — Net margin -98.2%
  • Cash Conversion Weak — Cash conversion (CFO/Rev) -108.8%
  • Sbc Revenue Elevated — SBC/Revenue 21.8%
  • Accumulated Deficit High — Accumulated deficit / equity 395%
  • Rd Intensity High — R&D/Revenue 71.7%

Upcoming earnings

1 event
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.15
Est. revenue
15.0M

Press & signals

3 of 5 recent
  • GlobeNewswire

    Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • GlobeNewswire

    Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • GlobeNewswire

    Invivyd Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of VYD2311 studies DECLARATION and LIBERTY

The rest of this company's wire — with summaries and source links — is part of Pro.

See plans

Documents

FormReporting forFiledFlags
2026-08-312026-09-020
2026-08-302026-09-010